Literature DB >> 27018980

Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice.

Monica Sala-Rabanal1,2, Bruce A Hirayama1, Chiara Ghezzi1, Jie Liu1, Sung-Cheng Huang1, Vladimir Kepe1,3, Hermann Koepsell4, Amy Yu1,5, David R Powell6, Bernard Thorens7, Ernest M Wright1, Jorge R Barrio1.   

Abstract

KEY POINTS: Glucose transporters are central players in glucose homeostasis. There are two major classes of glucose transporters in the body, the passive facilitative glucose transporters (GLUTs) and the secondary active sodium-coupled glucose transporters (SGLTs). In the present study, we report the use of a non-invasive imaging technique, positron emission tomography, in mice aiming to evaluate the role of GLUTs and SGLTs in controlling glucose distribution and utilization. We show that GLUTs are most significant for glucose uptake into the brain and liver, whereas SGLTs are important in glucose recovery in the kidney. This work provides further support for the use of SGLT imaging in the investigation of the role of SGLT transporters in human physiology and diseases such as diabetes and cancer. ABSTRACT: The importance of sodium-coupled glucose transporters (SGLTs) and facilitative glucose transporters (GLUTs) in glucose homeostasis was studied in mice using fluorine-18 labelled glucose molecular imaging probes and non-invasive positron emission tomography (PET) imaging. The probes were: α-methyl-4-[F-18]-fluoro-4-deoxy-d-glucopyranoside (Me-4FDG), a substrate for SGLTs; 4-deoxy-4-[F-18]-fluoro-d-glucose (4-FDG), a substrate for SGLTs and GLUTs; and 2-deoxy-2-[F-18]-fluoro-d-glucose (2-FDG), a substrate for GLUTs. These radiolabelled imaging probes were injected i.v. into wild-type, Sglt1(-/-) , Sglt2(-/-) and Glut2(-/-) mice and their dynamic whole-body distribution was determined using microPET. The distribution of 2-FDG was similar to that reported earlier (i.e. it accumulated in the brain, heart, liver and kidney, and was excreted into the urinary bladder). There was little change in the distribution of 2-FDG in Glut2(-/-) mice, apart from a reduction in the rate of uptake into liver. The major differences between Me-4FDG and 2-FDG were that Me-4FDG did not enter the brain and was not excreted into the urinary bladder. There was urinary excretion of Me-4FDG in Sglt1(-/-) and Sglt2(-/-) mice. However, Me-4FDG was not reabsorbed in the kidney in Glut2(-/-) mice. There were no differences in Me-4FDG uptake into the heart of wild-type, Sglt1(-/-) and Sglt2(-/-) mice. We conclude that GLUT2 is important in glucose liver transport and reabsorption of glucose in the kidney along with SGLT2 and SGLT1. Complete reabsorption of Me-4FDG from the glomerular filtrate in wild-type mice and the absence of reabsorption in the kidney in Glut2(-/-) mice confirm the importance of GLUT2 in glucose absorption across the proximal tubule.
© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018980      PMCID: PMC4967756          DOI: 10.1113/JP271904

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Molecular determinants of renal glucose reabsorption. Focus on "Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2".

Authors:  Volker Vallon
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-03       Impact factor: 4.249

2.  Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology.

Authors:  David Grundy
Journal:  J Physiol       Date:  2015-06-15       Impact factor: 5.182

3.  SGLT2 mediates glucose reabsorption in the early proximal tubule.

Authors:  Volker Vallon; Kenneth A Platt; Robyn Cunard; Jana Schroth; Jean Whaley; Scott C Thomson; Hermann Koepsell; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

Review 4.  Biology of human sodium glucose transporters.

Authors:  Ernest M Wright; Donald D F Loo; Bruce A Hirayama
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

5.  Synthesis and biologic evaluation of (11)c-methyl-d-glucoside, a tracer of the sodium-dependent glucose transporters.

Authors:  Guy M Bormans; Griet Van Oosterwyck; Tjibbe J De Groot; Maike Veyhl; Luc Mortelmans; Alfons M Verbruggen; Hermann Koepsell
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

6.  Multimodality rodent imaging chambers for use under barrier conditions with gas anesthesia.

Authors:  Chris Suckow; Claudia Kuntner; Patrick Chow; Robert Silverman; Arion Chatziioannou; David Stout
Journal:  Mol Imaging Biol       Date:  2008-08-05       Impact factor: 3.488

7.  Regional distribution of SGLT activity in rat brain in vivo.

Authors:  Amy S Yu; Bruce A Hirayama; Gerald Timbol; Jie Liu; Ana Diez-Sampedro; Vladimir Kepe; Nagichettiar Satyamurthy; Sung-Cheng Huang; Ernest M Wright; Jorge R Barrio
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-14       Impact factor: 4.249

8.  Molecular analysis of the SGLT2 gene in patients with renal glucosuria.

Authors:  René Santer; Martina Kinner; Christoph L Lassen; Reinhard Schneppenheim; Paul Eggert; Martin Bald; Johannes Brodehl; Markus Daschner; Jochen H H Ehrich; Markus Kemper; Salvatore Li Volti; Thomas Neuhaus; Flemming Skovby; Peter G F Swift; Jürgen Schaub; Dan Klaerke
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

9.  Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes.

Authors:  M T Guillam; R Burcelin; B Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

10.  Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.

Authors:  Valentin Gorboulev; Annette Schürmann; Volker Vallon; Helmut Kipp; Alexander Jaschke; Dirk Klessen; Alexandra Friedrich; Stephan Scherneck; Timo Rieg; Robyn Cunard; Maike Veyhl-Wichmann; Aruna Srinivasan; Daniela Balen; Davorka Breljak; Rexhep Rexhepaj; Helen E Parker; Fiona M Gribble; Frank Reimann; Florian Lang; Stefan Wiese; Ivan Sabolic; Michael Sendtner; Hermann Koepsell
Journal:  Diabetes       Date:  2011-11-28       Impact factor: 9.461

View more
  29 in total

1.  PET imaging of glucose movement into tissues in vivo sheds new light on an old problem.

Authors:  Chris Cheeseman
Journal:  J Physiol       Date:  2016-08-01       Impact factor: 5.182

2.  Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.

Authors:  Claudio R Scafoglio; Brendon Villegas; Gihad Abdelhady; Sean T Bailey; Jie Liu; Aditya S Shirali; W Dean Wallace; Clara E Magyar; Tristan R Grogan; David Elashoff; Tonya Walser; Jane Yanagawa; Denise R Aberle; Jorge R Barrio; Steven M Dubinett; David B Shackelford
Journal:  Sci Transl Med       Date:  2018-11-14       Impact factor: 17.956

Review 3.  SGLT2 Inhibitors: Physiology and Pharmacology.

Authors:  Ernest M Wright
Journal:  Kidney360       Date:  2021-09-17

4.  It's Not What You Take Up, It's What You Keep: How Discoveries from Diverse Disciplines Directed the Development of the FDG PET/CT Scan.

Authors:  Jonathan D Kaunitz; Mark Mandelkern; Joanna S Fowler
Journal:  Dig Dis Sci       Date:  2022-07-30       Impact factor: 3.487

5.  Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule.

Authors:  Chiara Ghezzi; Amy S Yu; Bruce A Hirayama; Vladimir Kepe; Jie Liu; Claudio Scafoglio; David R Powell; Sung-Cheng Huang; Nagichettiar Satyamurthy; Jorge R Barrio; Ernest M Wright
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

Review 6.  Glucose transporters in the kidney in health and disease.

Authors:  Volker Vallon
Journal:  Pflugers Arch       Date:  2020-03-06       Impact factor: 3.657

Review 7.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

8.  The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.

Authors:  Guillaume Arguin; Jean-François Bourzac; Morgane Placet; Caroline M Molle; Michel Paquette; Jean-François Beaudoin; Jacques A Rousseau; Roger Lecomte; Mélanie Plourde; Fernand-Pierre Gendron
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

Review 9.  Novel and Unexpected Functions of SGLTs.

Authors:  Ernest M Wright; Chiara Ghezzi; Donald D F Loo
Journal:  Physiology (Bethesda)       Date:  2017-11

Review 10.  SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.

Authors:  Tyler Sniegowski; Ksenija Korac; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.